FibriCheck vs ElucidVivo A.3

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

FibriCheck

by Qompium nv

ElucidVivo A.3

by Elucid

AI Verdict

FibriCheck is designed for remote heart rhythm monitoring and arrhythmia detection using a smartphone, focusing on ongoing patient surveillance. In contrast, ElucidVivo A.3 provides AI-powered quantitative analysis of arterial plaque from CT angiography to aid in atherosclerosis patient stratification and treatment decisions. While both tools contribute to cardiovascular care, they address distinct clinical needs: one for functional rhythm monitoring and the other for structural arterial assessment.

Choose FibriCheck if…

Choose FibriCheck if you need a convenient, patient-centric solution for remote heart rhythm monitoring and early detection of arrhythmias like AFib using a smartphone. This tool is ideal for ongoing patient engagement and providing healthcare providers with actionable data on cardiac rhythm outside of traditional clinical visits.

View FibriCheck →

Choose ElucidVivo A.3 if…

Choose ElucidVivo A.3 if you require advanced, AI-powered quantitative analysis of arterial plaque composition from CT angiography for precise atherosclerosis patient stratification. This system is best suited for cardiologists, radiologists, and vascular surgeons seeking detailed insights into plaque stability and morphology to optimize treatment strategies.

View ElucidVivo A.3 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	FibriCheck	ElucidVivo A.3
Pricing	Available via subscription for end-users (monthly/yearly) or through licensing agreements for healthcare providers and clinical centers.	Unknown
Deployment	Cloud-based digital application	Cloud and on-premise secure deployment.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FibriCheck

FibriCheck is a patient-facing mobile application that leverages a smartphone camera for heart rhythm monitoring, offering a highly accessible and intuitive user experience for individuals. ElucidVivo A.3 is a specialized medical image analysis system for physicians, requiring integration into complex clinical workflows, which generally implies a steeper learning curve for its specialized user base.

Clinical Value

ElucidVivo A.3

While FibriCheck provides valuable arrhythmia detection and monitoring, ElucidVivo A.3 offers deeper, quantitative analysis of arterial plaque composition and stability, validated against histology, and derives fractional flow reserve (FFRct). This provides more granular and impactful diagnostic insights for complex atherosclerosis management and treatment decision-making, with a higher level of clinical evidence (histology validation).

Pricing & Value

FibriCheck

FibriCheck offers transparent and varied pricing models for both end-users and healthcare providers, including monthly/yearly subscriptions and short-term options, with clearly stated costs. ElucidVivo A.3 requires direct contact for pricing, which lacks transparency and immediate accessibility for potential users.

Enterprise Readiness

ElucidVivo A.3

Both tools are FDA-cleared and imply HIPAA compliance. FibriCheck provides a professional portal and customizable rules for providers. However, ElucidVivo A.3's explicit integration with PACS/EMR systems is a critical and fundamental requirement for enterprise medical imaging solutions, demonstrating a deeper level of integration into core hospital IT infrastructure for its specialized domain.

Innovation

ElucidVivo A.3

FibriCheck's innovation lies in democratizing heart rhythm monitoring via a smartphone camera. ElucidVivo A.3's innovation is in providing highly quantitative, histologically validated analysis of arterial plaque composition and stability from standard CT scans, and deriving FFRct, offering non-invasive insights that previously required more invasive or less precise methods. This represents a significant advancement in diagnostic capabilities for complex cardiovascular disease.

Support & Docs

FibriCheck

FibriCheck provides a comprehensive online Help Center with user manuals for both individuals and healthcare providers, FAQs, and extensive developer documentation, including API integration guides and explicit support contact information. Publicly available information for ElucidVivo A.3's support and documentation is less detailed, focusing more on clinical validation and technical specifications rather than user support resources.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	FibriCheck	ElucidVivo A.3
Name	FibriCheck	ElucidVivo A.3
Primary Function	Medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone.	FDA-cleared AI-powered medical image analysis system that provides quantitative analysis of arterial plaque composition and stability from CT angiography.
Company	Qompium nv	Elucid Bioimaging
Categories	Cardiology AI, Wearables & Remote Monitoring (RPM)	Cardiology AI, Radiology & Imaging AI
Specialties	Cardiology, Family Medicine, Internal Medicine	Cardiology, Radiology, Vascular Surgery
Key Technology/Analysis	Smartphone camera-based PPG technology for heart rhythm measurement; AI-powered algorithm for arrhythmia detection and analysis.	AI-powered quantitative analysis of arterial plaque; objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images.

Videos

Demos, reviews, and walkthroughs featuring FibriCheck and ElucidVivo A.3.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate with existing EHR systems and imaging platforms to streamline data access and physician workflow?

FibriCheck offers API-based integration into existing EHRs, RPM platforms, and population health systems, allowing for seamless data flow and review within a healthcare professional portal. ElucidVivo A.3 is a software application that integrates with PACS/EMR systems, which is standard for medical imaging software, to process, review, and analyze digital images within typical clinical workflow patterns.

What are the specific accuracy and sensitivity metrics for arrhythmia detection (FibriCheck) or plaque characterization (ElucidVivo A.3), and how were these validated?

FibriCheck's AI algorithm for AF detection has demonstrated high overall performance with an accuracy of 98.5%, sensitivity of 96.3%, and specificity of 99.3% in multicenter validation studies, and is backed by over 100 peer-reviewed publications. ElucidVivo A.3 provides quantitative analysis of arterial plaque composition, including Lipid-Rich Necrotic Core, matrix, and calcifications, which is objectively quantified and validated against ground-truth histology, the gold standard for plaque characterization.

For which specific patient populations or clinical scenarios would each tool provide the most significant clinical value in my practice?

FibriCheck is most valuable for remote monitoring and early detection of atrial fibrillation and other arrhythmias in patients, particularly those with symptoms or at high risk, and can be used in cardiology, family medicine, and internal medicine settings. ElucidVivo A.3 is designed for stratifying patients with atherosclerosis by providing detailed quantitative analysis of arterial plaque composition from CT angiography, aiding in optimizing treatment decisions for cardiology, radiology, and vascular surgery specialties.

What is the typical learning curve for physicians and their staff to effectively utilize each tool, and what is the estimated time to realize clinical value?

FibriCheck is designed for ease of use, with a patient-facing mobile application and a provider portal that simplifies patient onboarding, follow-up, and analysis of recordings, leading to high patient satisfaction and compliance. ElucidVivo A.3 involves advanced image analysis and 3D visualization of plaque characteristics, which may require some training for interpretation, though its user interface follows typical clinical workflow patterns to process and review images.

Beyond standard compliance, what advanced security measures protect patient data, and what audit-trail capabilities are available for tracking data access and analysis?

While both tools imply HIPAA compliance due to their use in healthcare, specific advanced security measures beyond this, and detailed audit-trail features for tracking data access and modifications, are not explicitly detailed in the provided information for either FibriCheck or ElucidVivo A.3. FibriCheck does mention using IEC-62304 regulatory compliant cloud infrastructure and GDPR-safe data storage.

What kind of ongoing technical and clinical support is provided, and are there opportunities to connect with existing physician users for references or best practices?

FibriCheck emphasizes its extensive body of research and clinical evidence, with over 100 peer-reviewed publications, and offers opportunities to contact their clinical team for more information or collaboration. ElucidVivo A.3 is supported by documented validation against histopathology and peer-reviewed publications, and Elucid is committed to building a large repository of rigorous evidence. Specific details on ongoing technical and clinical support structures or direct customer reference programs for either tool are not explicitly provided.

What are the key considerations and support available for deploying these tools across multiple clinical sites or a larger healthcare system?

FibriCheck is a cloud-based digital application designed for scalability, with proven deployment across numerous healthcare systems and the ability to scale from one person to millions without device logistics. ElucidVivo A.3 is a software application that integrates with PACS/EMR, implying considerations for imaging infrastructure, and Elucid is conducting an international, multicenter study across at least 30 centers, suggesting support for multi-site deployment.